EH
VKTX icon

Equitable Holdings’s Viking Therapeutics VKTX Stock Holding History

Equitable Holdings’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Sell
11,000
-10,135
-48% -$327K ﹤0.01% 1383
2026
Q1 		$744K Buy
21,135
+14,678
+227% +$472K ﹤0.01% 1091
2025
Q4 		$227K Buy
+6,457
New +$229K ﹤0.01% 1458

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Equitable Holdings's VKTX Position: Q2 2026 in Review

Equitable Holdings reduced its Viking Therapeutics (VKTX) stake by 48% in Q2 2026, selling an estimated $327K and leaving 11,000 shares worth $429K. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Equitable Holdings first reported a position in VKTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $744K in Q1 2026. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Equitable Holdings held 11,000 shares of Viking Therapeutics worth $429K as of Q2 2026.
  • Equitable Holdings sold 10,135 Viking Therapeutics shares in Q2 2026, an estimated $327K.
  • Viking Therapeutics made up ﹤0.01% of Equitable Holdings's portfolio in Q2 2026, its #1383 holding.
  • Equitable Holdings first reported a position in Viking Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Equitable Holdings's Viking Therapeutics position peaked at $744K in Q1 2026.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.